Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
Open-market buys, last 90 days
$38,094
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Duncan Charles Cliff +$38K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2013-12-02 Polymeropoulos Mihael Hristos President and CEO Grant or award · Employee Stock Option (Right to Buy) +150,000 150,000
2013-12-02 Polymeropoulos Mihael Hristos President and CEO Grant or award · Restricted Stock Unit +50,000 50,000
2013-12-02 Kelly James Patrick SVP, CFO, Sec & Treasurer Grant or award · Employee Stock Option (Right to Buy) +60,000 60,000
2013-12-02 Kelly James Patrick SVP, CFO, Sec & Treasurer Grant or award · Restricted Stock Unit +20,000 20,000
2013-12-02 Baroldi Paolo SVP & Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +60,000 60,000
2013-12-02 Baroldi Paolo SVP & Chief Medical Officer Grant or award · Restricted Stock Unit +20,000 20,000
2013-11-21 Repella Robert SVP & Chief Commercial Officer Exercise or conversion +23,040 $5.90 $136K 44,530
2013-11-21 Repella Robert SVP & Chief Commercial Officer Exercise or conversion +34,570 $3.12 $108K 79,100
2013-11-21 Repella Robert SVP & Chief Commercial Officer Sale −64,100 $12.12 $777K 15,000
2013-11-21 Repella Robert SVP & Chief Commercial Officer Exercise or conversion · Employee Stock Option (Right to Buy) −23,040 166,445
2013-11-21 Repella Robert SVP & Chief Commercial Officer Exercise or conversion · Employee Stock Option (Right to Buy) −34,570 21,680
2013-11-20 Repella Robert SVP & Chief Commercial Officer Exercise or conversion +40,515 $5.90 $239K 62,005
2013-11-20 Repella Robert SVP & Chief Commercial Officer Sale −40,515 $11.89 $482K 21,490
2013-11-20 Repella Robert SVP & Chief Commercial Officer Exercise or conversion · Employee Stock Option (Right to Buy) −40,515 189,485
2013-11-19 Repella Robert SVP & Chief Commercial Officer Sale −2,885 $12.07 $35K 21,490
2013-11-19 Polymeropoulos Mihael Hristos President and CEO Sale −8,928 $12.07 $108K 471,636
2013-11-19 Kelly James Patrick SVP, CFO, Sec & Treasurer Sale −3,348 $12.07 $40K 28,816
2013-07-29 Repella Robert SVP & Chief Commercial Officer Exercise or conversion +9,375 24,375
2013-07-29 Repella Robert SVP & Chief Commercial Officer Exercise or conversion · Restricted Stock Unit −9,375 9,375
2013-07-29 Polymeropoulos Mihael Hristos President and CEO Exercise or conversion +25,000 480,564

Page 33 of 36 · 717 trades